Neil Mehta Greenoaks Capital Partners
Neil Mehta is a founder of Greenoaks Capital Partners, a firm focused on long-term investments in technology and internet businesses. Greenoaks is known for concentrated public portfolios and significant private growth investing. Mehta’s disclosed holdings often appear in discussions of high-conviction technology compounders.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$94.4M |
| 2 |
TSMC
TSM
|
+$67M |
| 3 |
SPCX
SpaceX
SPCX
|
+$43.8M |
| 4 |
CBRS
Cerebras Systems
CBRS
|
+$35.3M |
| 5 |
Carvana
CVNA
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NAVN
Navan Inc
NAVN
|
+$244M |
| 2 |
Veeva Systems
VEEV
|
+$43.9M |
| 3 |
FIG
Figma
FIG
|
+$31.7M |
| 4 |
BBB Foods
TBBB
|
+$9.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 87.02% |
| 2 | Technology | 11.11% |
| 3 | Industrials | 1.87% |
| 4 | Consumer Staples | 0% |
| 5 | Healthcare | 0% |
Similar funds
Neil Mehta's Q2 2026 Portfolio in Review
As of Q2 2026, Neil Mehta held 13 positions worth $2.36B, up 2.6% from $2.3B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Neil Mehta's Q2 2026 filing shows 3 new, 3 increased, 1 reduced and 3 closed positions. Its largest new stake was TSMC: 165,000 shares worth $78.8M. The largest sale was Navan Inc, an estimated $244M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 87% of assets, up from 83% a quarter earlier, followed by Technology and Industrials.
- Neil Mehta's largest Q2 2026 buy was TSMC: 165,000 shares worth $78.8M.
- Neil Mehta added most to Amazon in Q2 2026, an estimated $94.4M increase.
- Neil Mehta's biggest Q2 2026 reduction was Navan Inc, cutting an estimated $244M.
- Neil Mehta fully exited Veeva Systems in Q2 2026, selling an estimated $43.9M.
- Neil Mehta's ten largest holdings make up 100% of its $2.36B portfolio in Q2 2026.
- Neil Mehta opened 3 new positions and closed 3 in Q2 2026.
- Neil Mehta's portfolio value rose 2.6% quarter-over-quarter to $2.36B.
Based on Greenoaks Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.